{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:35:10Z","timestamp":1792787710858,"version":"4.5.0"},"reference-count":17,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Bhumibol Adulyadej Hospital","id":[{"id":"https:\/\/ror.org\/041e85345","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Infection"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early oral antiviral treatment reduced disease progression and hospitalisation in high-risk COVID-19 outpatients. In practice, prescribing decisions were influenced by clinical risk, drug interaction concerns, and physician judgment, even in settings where guidelines prioritised nirmatrelvir\/ritonavir. This study aimed to identify the patient characteristics that independently predicted oral antiviral selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify (1) independent predictors of nirmatrelvir\/ritonavir versus molnupiravir prescribing, and (2) predictors of receiving any potent antiviral versus no potent antiviral, among high-risk COVID-19 outpatients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from Bhumibol Adulyadej Hospital in Bangkok, Thailand, this retrospective cohort study enrolled 450 COVID-19 outpatients between April 2022 and June 2023. Participants were randomly selected into three treatment groups of 150 each: nirmatrelvir\/ritonavir, molnupiravir, and no antiviral. Multivariate logistic regression was applied to identify independent predictors of drug selection across demographics, comorbidities, and concomitant medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Treated patients were older than those who received no antiviral, with mean ages of 61.68 and 62.91 years in the nirmatrelvir\/ritonavir and molnupiravir groups versus 43.89 years in the no-treatment cohort (p &lt; 0.001). Comorbid disease was more prevalent in both antiviral groups. When nirmatrelvir\/ritonavir and molnupiravir recipients were compared directly, concurrent statin use was the only variable that independently predicted a lower probability of nirmatrelvir\/ritonavir being chosen (adjusted OR 0.46; 95% CI 0.27 to 0.79; p = 0.005).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Older patients and those carrying a greater comorbidity burden were prioritised for antiviral treatment in this Thai outpatient cohort. Drug\u2013drug interaction concerns, particularly between ritonavir and statins, drove physicians toward molnupiravir even when nirmatrelvir\/ritonavir would otherwise have been the preferred agent. Systematic incorporation of pharmacist-conducted medication assessment before antiviral prescribing represents a practicable strategy for reducing avoidable drug substitution in high-risk patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20499361261473780","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:18:20Z","timestamp":1789442300000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic factors in the selection of antivirals for COVID-19 in high-risk outpatients: A retrospective cohort study"],"prefix":"10.1177","volume":"13","author":[{"given":"Puttirat","family":"Bunditwongpaisan","sequence":"first","affiliation":[{"name":"Bhumibol Adulyadej Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7154-2501","authenticated-orcid":false,"given":"Natthakit","family":"Chavapradit","sequence":"additional","affiliation":[{"name":"Bhumibol Adulyadej Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239250"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118542"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116044"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1147980"},{"key":"e_1_3_8_7_2","volume-title":"Coronavirus disease 2019 (COVID-19) treatment guidelines","author":"COVID-19 Treatment Guidelines Panel","year":"2023","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health, 2023. https:\/\/www.covid19treatmentguidelines.nih.gov (Accessed May 13, 2026)."},{"key":"e_1_3_8_8_2","unstructured":"Department of Medical Service (Thailand). Thailand clinical practice guideline for COVID-19. https:\/\/covid19.dms.go.th (2023) Accessed May 13 2026."},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00910-1"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57633-7"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7339a3"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.06.059"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/M22-0281"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.08.800"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293302"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5869"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7143a2"}],"container-title":["Therapeutic Advances in Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20499361261473780","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20499361261473780","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20499361261473780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:46:22Z","timestamp":1789767982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20499361261473780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":17,"alternative-id":["10.1177\/20499361261473780"],"URL":"https:\/\/doi.org\/10.1177\/20499361261473780","relation":{},"ISSN":["2049-9361","2049-937X"],"issn-type":[{"value":"2049-9361","type":"print"},{"value":"2049-937X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"article-number":"20499361261473780"}}